BALYASNY ASSET MANAGEMENT L.P. - PEAR THERAPEUTICS INC ownership

PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723113. A total of 36 filers reported holding PEAR THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BALYASNY ASSET MANAGEMENT L.P. ownership history of PEAR THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$2,766
-87.6%
145,600
-2.9%
0.00%
Q4 2022$22,335
-10.7%
150,0000.0%0.00%
Q3 2022$25,000
+8.7%
150,0000.0%0.00%
Q2 2022$23,000
-80.7%
150,0000.0%0.00%
Q1 2022$119,000
+32.2%
150,0000.0%0.00%
Q4 2021$90,000150,0000.00%
Other shareholders
PEAR THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
LMR Partners LLP 2,440,169$622,2430.01%
DIFESA CAPITAL MANAGEMENT, LP 551,435$10,4770.01%
Silver Rock Financial LP 188,505$3,6000.00%
Q Global Advisors, LLC 250,000$50.00%
ANGELO GORDON & CO., L.P. 33,332$8,5000.00%
Arena Investors LP 126,122$2,3960.00%
ADVISORY RESEARCH INC 202,891$3,8550.00%
MILLENNIUM MANAGEMENT LLC 765,000$150.00%
WOLVERINE ASSET MANAGEMENT LLC 19,302$3680.00%
Owl Creek Asset Management, L.P. 414,000$7,9070.00%
View complete list of PEAR THERAPEUTICS INC shareholders